A Day Up For Marinus Pharmaceuticals, Inc.
Tue, Sep 15, 2020 at 05:30 PM
Marinus Pharmaceuticals, Inc. (MRNS:NASDAQ) shot up at $3.2, representing a gain of 51.7%. On Mon 14 Sep 20, MRNS:NASDAQ hit a New 2-Week High of $2.11. The stock appeared on our News Catalysts scanner on Tue 15 Sep 20 at 11:42 AM in the 'MISCELLANEOUS' category. From Mon 31 Aug 20, the stock recorded 55.56% Up Days and 30.00% Green Days
The stock spiked on Tue 16 Jun 20 at $3.5 with a volume of 8M+, and its share price has been moving sideways in recent weeks.
About Marinus Pharmaceuticals, Inc. (MRNS:NASDAQ)
Marinus Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders.
Top 10 Gainers:
- Novus Therapeutics, Inc. (NVUS:NASDAQ), 192.88%
- Marinus Pharmaceuticals, Inc. (MRNS:NASDAQ), 51.66%
- IPOB (IPOB:NYSE), 34.56%
- Oasis Petroleum Inc. (OAS:NASDAQ), 28.34%
- Superior Drilling Products, Inc. (SDPI:NYSEMKT), 24.27%
- Plus Therapeutics, Inc. (PSTV:NASDAQ), 24.18%
- Jounce Therapeutics, Inc. (JNCE:NASDAQ), 23.73%
- Ocwen Financial Corporation (OCN:NYSE), 23.61%
- Kosmos Energy Ltd. (KOS:NYSE), 22.77%
- Mexco Energy Corporation (MXC:NYSEMKT), 20.95%